EVGN logo
EVGN NASDAQ IL

Evogene Ltd. - Ordinary Shares

Healthcare · Biotechnology Website · IPO Jun 2007
$0.78
▼ $-0.03 (-3.70%)
Vol 45K
7
Quality Score
fail
Mkt Cap
$9.6M
ROE
339.2%
Margin
-52.4%
D/E
220.67
Beta
1.33
52W
$1–$2

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

CMMB
Chemomab Therapeutics Ltd
$10.1M
QNRX
Quoin Pharmaceuticals Ltd
$8.5M
CLGN
Collplant Biotechnologies Ltd
$17.8M
SLXN
Silexion Therapeutics Corp
$6.0M
GLMD
Galmed Pharmaceuticals Ltd
$4.1M
SCNI
Scinai Immunotherapeutics Ltd
P/E 0.1
$612K
URGN
Urogen Pharma Ltd
$1.1B

Earnings

Beat rate: 75.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.27 $-0.61 $-0.34
Sep 2025 $-0.42 $0.44 +$0.86
Jun 2025 $-0.64 $-0.62 +$0.02
Mar 2025 $-0.46 $-0.38 +$0.08

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) — -189.8% -189.8% -189.8% 339.2% 339.2%
P/E (TTM) — — — — — —
Net Margin -504.9% -224.8% -211.6% -211.6% -52.4% -52.4%
Gross Margin 84.2% 41.1% 46.8% 46.8% 49.2% 49.2%
D/E Ratio — 365.24 365.24 365.24 220.67 220.67
Current Ratio 1.89 1.06 1.89 1.89 5.11 5.11

Key Ratios

ROA (TTM)
-8.2%
P/S (TTM)
1.83
P/B
3.5
EPS (TTM)
$-0.49
CF/Share
$-0.46
Rev Growth 3Y
+109.2%
52W High
$2.42
52W Low
$0.95
$0.95 52-Week Range $2.42

How does EVGN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

EVGN AAPG ABEO ABOS ABP

EVGN valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1.8
▼ 86% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
3.5
▲ 43% above peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

EVGN profitability vs Biotechnology peers

ROE
339.2%
▲ 604% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-52.4%
▲ 82% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
49.2%
▼ 37% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-8.2%
▲ 82% above peers (-46.7%)
vs Peers
vs Industry
Top tier

EVGN financial health vs Biotechnology peers

D/E ratio
220.7
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
5.1
▲ 15% above peers (4.4)
vs Peers
vs Industry
In line
Beta
1.3
▲ 37% above peers (1.0)
vs Peers
vs Industry
More volatile

EVGN fundamentals radar

EVGN Peer median Industry

EVGN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

EVGN vs peers: key metrics

Latest News

No related news yet